|(NOK in millions)||2013 Pro forma (unaudited)||2014 Pro forma (unaudited)|
|EBITDA margin||5.8 %||5.9 %|
|Adjusted EBITDA 2)||713.9||724.5|
|Adjusted EBITDA margin||0.1||0.1|
|Net cash flow from operating activities||n.a.||347.6|
|Capital expenditures 3)||209.6||153.6|
|Net interest bearing debt||n.a.||4,227.4|
1) EBITDA represents operating results before fair value adjustments of biological assets, depreciation and amortisation, less advisory fees charged by Altor and Bain
2) Adjusted EBITDA represents EBITDA as adjusted for certain non-recurring and/or non-cash costs.
3) Capital expenditures reported represent the cash effects of purchases of property, plant and equipment.